切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2022, Vol. 19 ›› Issue (03) : 200 -205. doi: 10.3877/cma.j.issn.1672-6448.2022.03.003

腹部超声影像学

超声造影与增强MRI对高分化肝癌和异型增生结节的诊断
范培丽1, 毛枫1, 季正标1, 曹佳颖1, 盛若凡2, 王文平1,()   
  1. 1. 200032 上海,复旦大学附属中山医院超声科;200032 上海,复旦大学附属中山医院放射科;200032 上海,上海市影像医学研究所
    2. 200032 上海,复旦大学附属中山医院放射科;200032 上海,复旦大学超声医学与工程研究所
  • 收稿日期:2020-06-08 出版日期:2022-03-01
  • 通信作者: 王文平
  • 基金资助:
    上海市临床重点专科项目经费资助(shslczdzk03501); 上海申康中心重大临床研究项目(SHDC2020CR1031B); 上海市自然科学基金项目(20ZR1452800)

Contrast-enhanced ultrasound versus contrast-enhanced MRI for diagnosis of well-differentiated hepatocellular carcinoma and precancerous lesions

Peili Fan1, Feng Mao1, Zhengbiao Ji1, Jiaying Cao1, Ruofan Sheng2, Wenping Wang1,()   

  1. 1. Department of Ultrasound, Zhongshan Hospital, Fudan University, Shanghai 200032, China; Shanghai Institute of Medical Imaging, Shanghai 200032, China; Institute of Ultrasound in Medicine and Engineering, Fudan University, Shanghai 200032, China
    2. Shanghai Institute of Medical Imaging, Shanghai 200032, China; Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China
  • Received:2020-06-08 Published:2022-03-01
  • Corresponding author: Wenping Wang
引用本文:

范培丽, 毛枫, 季正标, 曹佳颖, 盛若凡, 王文平. 超声造影与增强MRI对高分化肝癌和异型增生结节的诊断[J]. 中华医学超声杂志(电子版), 2022, 19(03): 200-205.

Peili Fan, Feng Mao, Zhengbiao Ji, Jiaying Cao, Ruofan Sheng, Wenping Wang. Contrast-enhanced ultrasound versus contrast-enhanced MRI for diagnosis of well-differentiated hepatocellular carcinoma and precancerous lesions[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2022, 19(03): 200-205.

目的

探讨超声造影与增强MRI对高分化肝细胞癌和肝异型增生结节(DN)的诊断能力。

方法

回顾性收集2012年1月至2018年12月在复旦大学附属中山医院同期行超声造影和增强MRI检查并获病理学证实的39例患者的39个高分化肝细胞癌病灶和7例患者的8个DN病灶,分析其超声造影和增强MRI表现特征。采用χ2检验,计算Kappa值,比较2种检查方法的诊断一致性;绘制不同检查方法的受试者操作特征(ROC)曲线,分析其诊断效能。

结果

2种诊断方法中,69.2%(27/39)的高分化肝细胞癌的动脉期表现一致(Kappa=0.482),53.8%(21/39)的高分化肝细胞癌的延迟期表现一致(Kappa=0.168)。DN病灶在超声造影的主要表现呈“等增强-等增强”模式(87.5%,7/8),增强MRI主要表现为“高信号-低信号”模式(62.5%,5/8),所有DN病灶在超声造影延迟期均未出现廓清。超声造影、增强MRI、超声造影联合增强MRI(同时满足或只满足一种)4种检查方法中,超声造影联合增强MRI(只满足一种)诊断高分化肝细胞癌的敏感度(66.7%)和准确性(61.7%)最高,而超声造影诊断高分化肝细胞癌的特异度(100%)和ROC曲线下面积(0.658,95%CI:0.482~0.834)最高。

结论

超声造影联合增强MRI有助于高分化肝细胞癌和肝DN的鉴别诊断,而超声造影具有更高的诊断特异度。

Objective

To evaluate the diagnostic performance of contrast-enhanced ultrasound and contrast-enhanced MRI for well-differentiated hepatocellular carcinoma (HCC) and dysplastic nodules (DNs).

Methods

Thirty-nine patients with 39 well-differentiated HCC and seven patients with eight DNs pathologically confirmed who underwent contrast-enhanced ultrasound (CEUS) and enhanced MRI at Zhongshan Hospital of Fudan University from January 2012 to December 2018 were enrolled. Imaging features and diagnostic efficacy of the two imaging methods were analyzed. Chi-square test and Kappa value were used to compare the consistency of the two imaging methods. Receiver operator characteristic (ROC) curve analysis was performed to calculate the diagnostic efficiency of the two imaging methods.

Results

For the two imaging methods, the consistency of arterial phase enhancement patterns of well-differentiated HCC was 69.2% (27/39) and Kappa value was 0.482. The consistency of late phase enhancement patterns of well-differentiated HCC was 53.8% (21/39) and Kappa value was 0.168. The major enhancement pattern of DNs was "iso-enhancement~iso-enhancement" on CEUS, and "hyperintensity~hypointensity" on contrast-enhanced MRI. No DNs exhibited washout in the late phase on CEUS. Among the four examination methods, CEUS, enhanced MRI, and CEUS combined with enhanced MRI (detected by both or by either), the sensitivity (66.7%) and accuracy (61.7%) of CEUS combined with enhanced MRI (detected by either) were highest for the diagnosis of well-differentiated HCC, while CEUS had the highest specificity (100%) and area under the ROC curve (0.658, 95%CI: 0.482-0.834).

Conclusion

CEUS combined with enhanced MRI is helpful for differential diagnosis of well-differentiated HCC and DNs, while CEUS has a higher specificity.

图1 82 岁男性高分化肝细胞癌病例超声造影及增强MRI 图像。图a 为常规灰阶超声显示肝右叶见29 mm×20 mm稍高回声病灶(箭头所示);图b为超声造影动脉期病灶(17 s)呈高回声增强(箭头所示),内见小片状未增强区(*);图c 为超声造影延迟期(180 s),病灶出现造影剂不均匀廓清呈低回声增强(箭头所示);图d 为增强MRI 动脉期,病灶强化呈高信号(箭头),内见较大范围未强化区(*);图e为增强MRI延迟期,病灶周边强化进展(高信号范围增大,箭头所示),中央见未强化区
表1 39个高分化肝细胞癌病灶超声造影与增强MRI动脉期表现比较(个)
表2 39个高分化肝细胞癌病灶超声造影与增强MRI延迟期表现比较(个)
图2 54岁男性肝异型增生结节病例超声、增强MRI和病理图像。图a为常规灰阶超声显示肝右叶下角见8 mm×8 mm等回声团块,边界不清(箭头所示);图b 为超声造影动脉期(22 s)病灶呈整体高回声增强(箭头);图c 为超声造影延迟期(344 s),病灶仍呈高回声增强(箭头);图d 为增强MRI动脉期,病灶呈高信号强化(箭头);图e 为增强MRI延迟期,病灶廓清呈低信号(箭头);图f 为镜下病理图片,显示细胞较小,中度异型,密度增加,核/浆比增高(HE×200)
表3 8个异型增生结节病灶的超声造影与增强MRI动脉期-延迟期表现比较(个)
图3 超声造影和增强MRI诊断高分化肝细胞癌的受试者操作特征曲线注:超声造影联合增强MRI 1为超声造影和增强MRI其中一种符合肝细胞癌诊断标准;超声造影联合增强MRI 2为超声造影和增强MRI同时符合肝细胞癌诊断标准
表4 超声造影和增强MRI对高分化肝细胞癌的诊断效能比较[%(个/个)]
1
Omata M, Cheng A, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update [J]. Hepatol Int, 2017, 11(4): 317-370.
2
Galle PR, Forner A, Llovet JM, et al. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma [J]. J Hepatol, 2018, 69(1): 182-236.
3
Aube C, Oberti F, Lonjon J, et al. EASL and AASLD recommendations for the diagnosis of HCC to the test of daily practice [J]. Liver Int, 2017, 37(10): 1515-1525.
4
International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia [J]. Hepatology, 2009, 49(2): 658-664.
5
Sato T, Kondo F, Ebara M, et al. Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up study [J]. Hepatol Int, 2015, 9(2): 330-336.
6
Claudon M, Dietrich CF, Choi BI, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS [J]. Ultraschall Med, 2013, 34(1): 11-29.
7
Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma [J]. Hepatology, 2018, 67(1): 358-380.
8
Jang HJ, Kim TK, Burns PN, et al. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: Comparison with histologic differentiation [J]. Radiology, 2007, 244(3): 898-906.
9
Chou CT, Chou JM, Chang TA, et al. Differentiation between dysplastic nodule and early-stage hepatocellular carcinoma: the utility of conventional MR imaging [J]. World J Gastroenterol, 2013, 19(42): 7433-7439.
10
Takahashi M, Maruyama H, Ishibashi H, et al. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma [J]. AJR Am J Roentgenol, 2011, 196(2): 123-131.
11
Di Martino M, Anzidei M, Zaccagna F, et al. Qualitative analysis of small (≤2 cm) regenerative nodules, dysplastic nodules and well-differentiated HCCs with gadoxetic acid MRI [J]. Bmc Med Imaging, 2016, 16(1): 62.
12
严福华, 周康荣, 沈继章, 等. MR和CT动态扫描对小肝癌强化特征的比较研究 [J]. 中华肿瘤杂志, 2001, 23(5): 413-416.
13
Burns PN, Wilson SR. Focal liver masses: enhancement patterns on contrast-enhanced images--concordance of US scans with CT scans and MR images [J]. Radiology, 2007, 242(1): 162-174.
14
Shin SK, Kim YS, Choi SJ, et al. Contrast-enhanced ultrasound for the differentiation of small atypical hepatocellular carcinomas from dysplastic nodules in cirrhosis [J]. Dig Liver Dis, 2015, 47(9): 775-782.
15
Park YN, Yang CP, Fernandez GJ, et al. Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver [J]. Am J Surg Pathol, 1998, 22(6): 656-662.
16
林满霞, 徐辉雄, 谢晓燕, 等. 肝硬化基础上低度和高度不典型增生结节的超声造影表现 [J]. 中华超声影像学杂志, 2009, 18(12): 1057-1060.
17
黄斌, 孙希希, 荀运浩, 等. 常规二维超声联合超声造影对肝硬化背景肝内结节分类及临床应用价值 [J/CD]. 中华医学超声杂志(电子版), 2017, 14(4): 297-301.
18
Kim BR, Lee JM, Lee DH, et al. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging versus multidetector CT in the detection of dysplastic nodules and early hepatocellular carcinoma [J]. Radiology, 2017, 285(1): 134-146.
19
Ohama H, Imai Y, Nakashima O, et al. Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI [J]. J Gastroenterol, 2014, 49(6): 1081-1093.
20
Sangiovanni A, Manini MA, Iavarone M, et al. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis [J]. Gut, 2010, 59(5): 638-644.
[1] 张婉微, 秦芸芸, 蔡绮哲, 林明明, 田润雨, 金姗, 吕秀章. 心肌收缩早期延长对非ST段抬高型急性冠脉综合征患者冠状动脉严重狭窄的预测价值[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1016-1022.
[2] 任书堂, 刘晓程, 张亚东, 孙佳英, 陈萍, 周建华, 龙进, 黄云洲. 左心室辅助装置支持下单纯收缩期主动脉瓣反流的超声心动图特征[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1023-1028.
[3] 何金梅, 尹立雪, 谭静, 张文军, 王锐, 任梅, 廖明娇. 超声心肌做功技术对2型糖尿病患者潜在左心室心肌收缩功能损伤的评价[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1029-1035.
[4] 薛艳玲, 马小静, 谢姝瑞, 何俊, 夏娟, 何亚峰. 左心声学造影在急性心肌梗死合并室间隔穿孔中的应用价值[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1036-1039.
[5] 吕琦, 惠品晶, 丁亚芳, 颜燕红. 颈动脉斑块易损性的超声造影评估及与缺血性卒中的相关性研究[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1040-1045.
[6] 魏淑婕, 惠品晶, 丁亚芳, 张白, 颜燕红, 周鹏, 黄亚波. 单侧颈内动脉闭塞患者行颞浅动脉-大脑中动脉搭桥术的脑血流动力学评估[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1046-1055.
[7] 武玺宁, 欧阳云淑, 张一休, 孟华, 徐钟慧, 张培培, 吕珂. 胎儿心脏超声检查在抗SSA/Ro-SSB/La抗体阳性妊娠管理中的应用[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1056-1060.
[8] 杨水华, 何桂丹, 覃桂灿, 梁蒙凤, 罗艳合, 李雪芹, 唐娟松. 胎儿孤立性完全型肺静脉异位引流的超声心动图特征及高分辨率血流联合时间-空间相关成像的应用[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1061-1067.
[9] 张璇, 马宇童, 苗玉倩, 张云, 吴士文, 党晓楚, 陈颖颖, 钟兆明, 王雪娟, 胡淼, 孙岩峰, 马秀珠, 吕发勤, 寇海燕. 超声对Duchenne肌营养不良儿童膈肌功能的评价[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1068-1073.
[10] 张宝富, 俞劲, 叶菁菁, 俞建根, 马晓辉, 刘喜旺. 先天性原发隔异位型肺静脉异位引流的超声心动图诊断[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1074-1080.
[11] 丁雷, 罗文, 杨晓, 庞丽娜, 张佩蒂, 刘海静, 袁佳妮, 刘瑾. 高帧频超声造影在评价C-TIRADS 4-5类甲状腺结节成像特征中的应用[J]. 中华医学超声杂志(电子版), 2023, 20(09): 887-894.
[12] 张茜, 陈佳慧, 高雪萌, 赵傲雪, 黄瑛. 基于高帧频超声造影的影像组学特征鉴别诊断甲状腺结节良恶性的价值[J]. 中华医学超声杂志(电子版), 2023, 20(09): 895-903.
[13] 冯冰, 邹秋果, 梁振波, 卢艳明, 曾奕, 吴淑苗. 老年非特殊型浸润性乳腺癌超声征象与分子生物学指标的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 48-51.
[14] 赵文毅, 邹冰子, 蔡冠晖, 刘永志, 温红. 超声应变力弹性成像联合MRI-DWI靶向引导穿刺在前列腺病变诊断中的应用[J]. 中华临床医师杂志(电子版), 2023, 17(9): 988-994.
[15] 薛念余, 张盛敏, 吴凌恒, 沙蕾, 童揽月, 沈崔琴, 李朝军, 杜联芳. 研究血清胆红素对2型糖尿病患者心脏结构发生改变前心肌功能的影响[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1004-1009.
阅读次数
全文


摘要